Beneficient BENF.OQ BENF.O is expected to show a rise in quarterly revenue when it reports results on November 10 (estimated) for the period ending September 30 2025
The Dallas Texas-based company is expected to report a 82.9% increase in revenue to $15.658 million from $8.56 million a year ago, according to the estimate from one analyst, based on LSEG data.
LSEG's mean analyst estimate for Beneficient is for a loss of 31 cents per share.
The mean earnings estimate of analysts had fallen by about 107.7% in the last three months.
Wall Street's median 12-month price target for Beneficient is $2.00, about 73.6% above its last closing price of $0.53
This summary was machine generated November 7 at 14:26 GMT. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)
Comments